Thera Tech.

PositionInvestment contract with Sam Yang Group - Brief Article

TheraTech, a drug delivery technology company, announced it has signed a multimillion dollar equity agreement with the Sam Yang Group of Korea. In addition to the equity investment, Sam Yang will license and market in Korea pharmaceutical products developed by TheraTech. Sam Yang has also made a major equity investment in...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT